UBS Group AG - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 37 filers reported holding NOVELION THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.56 and the average weighting 0.2%.

Quarter-by-quarter ownership
UBS Group AG ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$3,000
+200.0%
3,823
+129.5%
0.00%
Q2 2019$1,000
-87.5%
1,666
-72.9%
0.00%
Q1 2019$8,0006,148
+1112.6%
0.00%
Q4 2018$0
-100.0%
507
-92.1%
0.00%
Q3 2018$19,000
+171.4%
6,421
+228.1%
0.00%
Q2 2018$7,0001,957
+7148.1%
0.00%
Q1 2018$0
-100.0%
27
-96.3%
0.00%
Q4 2017$2,000
-50.0%
724
+35.1%
0.00%
Q3 2017$4,000536
+1885.2%
0.00%
Q2 2017$0
-100.0%
27
-96.6%
0.00%
Q1 2017$8,000
-42.9%
801
-53.6%
0.00%
Q4 2016$14,0001,7260.00%
Other shareholders

There were no reported owners of NOVELION THERAPEUTICS INC in Q4 2018.

NameSharesValueWeighting ↓
View complete list of NOVELION THERAPEUTICS INC shareholders